Aims-To investigate the effects of aspirin administered with placebo or antioxidants on gastric mucosal reactive oxygen metabolite release and gastroduodenal injury in human volunteers. Subjects-Fourteen healthy volunteers participated in the study (seven male; mean age 27 years, range (Gut 1996; 38: 518-524) Keywords: allopurinol, sulphasalazine, vitamin C, aspirin, gastroduodenal injury.
Aspirin causes acute gastric mucosal injury in virtually all subjects' and longterm use is associated with gastric ulceration, and both gastric and duodenal ulcer bleeding.2 The mechanisms of injury are diverse and are not all fully understood. It seems, however, that aspirin damages the mucosal barrier, permitting the back diffusion of hydrogen ions, and inhibits prostaglandin synthesis by acetylating cyclooxygenase, thereby impairing mucosal blood flow, bicarbonate, and mucus secretion and epithelial cell hydrophobicity. 2 Recent work suggests that neutrophil infiltration occurs early in non-steroidal antiinflammatory drug (NSAID) induced gastric mucosal injury3 and that neutrophil derived free oxygen radicals are probably contributory.4 Free oxygen radicals have been shown to have an important role in several animal models of ischaemic injury,-7 which is known to occur after topical application of aspirin and hydrochloric acid to rat stomachs.8 9 It seems probable, therefore, that reactive oxygen species released during inflammation and ischaemia may be a further mechanism of injury induced by aspirin.
Antioxidants have been successfully used in animals to reduce gastric injury induced by ischaemia,5-7 aspirin,10 11 and indomethacin.4 11 12 One study found that allopurinol improved healing in patients presenting with bleeding from NSAID induced gastric erosions,13 but effect on oxygen radical release was not investigated.
In this study, we have measured the reactive oxygen metabolite response to aspirin by measuring luminol and lucigenin amplified chemiluminescence from gastric mucosal biopsy specimens. In the presence of these oxidants, luminol and lucigenin form 3-aminophthalate and N-methylacridone, electronically excited compounds that emit light energy (chemiluminescence) on reverting to the ground state, which can be measured in a scintillation counter. We 
Endoscopy
Unsedated endoscopy was performed by the same endoscopist in all subjects before and after each treatment phase. The presence of erythema and the number of erosions (haemorrhagic and non-haemorrhagic), ulcers, intramucosal haemorrhages, and surface flecks of blood were recorded for oesophagus, gastric body, antrum, and duodenum. Injury was also quantified using a modified Lanza scale (Table) . '4 Chemiluminescence Biopsy specimens were taken from the antrum on the greater curve for measurement of both luminol and lucigenin amplified chemiluminescence. Each specimen was immediately washed in phosphate buffered saline containing 5 mmol/l glucose (pH 7.4) and transferred to a dark adapted scintillation vial containing 1 ml luminol or lucigenin (both at 300 ,umol/l). All solutions were pre-oxygenated. Chemiluminescence was measured over five minutes in a LKB Wallac P scintillation counter (model 1214) operating in out of coincidence mode. Specimens were then carefully blotted dry and weighed and chemiluminescence expressed as counts per minute per gram of tissue (cpm/g).
Prostanoids
Ex vivo synthesis of prostaglandin E2 (PGE2) by antral mucosal biopsy specimens taken from the greater curve was measured by radioimmunoassay as previously described.'5 Samples were washed in 1 ml TRIS saline, vortex mixed, and centrifuged at high speed twice, after which the supematant was discarded. On the third occasion, 0.3 ml TRIS saline was added to each specimen followed again by vortex mixing and centrifugation. .E subjects before (day 0) and after ( (Fig 3) .
Lucigenin amplified chemiluminescence increased in nine of 14 subjects after aspirin and placebo. The mean baseline value of 1.3X107 (3.7X106) cpmlg increased to 20X 1i07 (7.8X 106) cpmlg after treatment, but this did not reach statistical significance (p=0.2, Fig 2) . Aspirin given in conjunction with vitamin C produced an insignificant reduction in mean lucigenin amplified chemiluminescence value, which fell from a baseline of 1.3X107 (3.1X106) cpmlg to 11X107 (2-5X 106) cpm/g (Fig 3) . Reductions in mean values occurred after aspirin with allopurinol, from a baseline of 15X 107 (9*2X 106) cpm/g to 7.5X 106 (1*5X 106) cpm/g (p=0.6, NS) and after aspirin and sulphasalazine, from 9.3>X 106 (3.3X 106) cpm/g to 7.7X 106 (1.3X 106) cpm/g (p=0.2, NS).
Mucosal injury
No subject had erosions or ulcers in any area at baseline investigation (Lanza grade 0-1). Oesophagitis was present in two subjects after a total of three treatment periods, but no oesophageal injury was sustained by the remaining 12 subjects throughout the study. The median Lanza score in the gastric body was 2 (range 1-4) after treatment with aspirin and placebo, and 2-5 (0-4) after each of the other treatment phases (aspirin with either allopurinol, sulphasalazine or vitamin C). After treatment with aspirin and placebo the median Lanza grade in the antrum was 3 (2-4), compared with 2 (0-4) after cotreatment with either allopurinol or sulphasalazine and 3 (0-4) with vitamin C. The combined scores (for antrum and body) were 4 (2-4) after aspirin and placebo, 4 (1-4) after aspirin and either allopurinol or vitamin C, and 3-5 (0-4) after coadministration with sulphasalazine ( Fig  4) . Duodenal injury reached a median value of grade 2 (0-4) (Fig 5) Aspirin + placebo Duodenal ulcers developed in no subject given vitamin C, but did in two subjects in each of the placebo and allopurinol groups and in three of the sulphasalazine group. All ulcers, defined as lesions causing definite epithelial disruption in the mucosal surface and measuring at least 3 mm in diameter, were superficial and healed spontaneously and completely by the time of the next endoscopy.
Vitamin C Discussion Our study shows that aspirin induced gastric Sulphasalazine mucosal injury in humans is associated with an Allopurinol increase in the release of reactive oxygen metabolites, which may themselves contribute to mucosal injury. 4 In addition to stimulated neutrophils, a further source of reactive oxygen species in the stomach might be endothelial xanthine oxidase, formed by conversion from the dehydrogenase after an ischaemic injury, and capable of converting molecular oxygen to the superoxide after reperfusion. Studies in dogs have shown that topical aspirin induces pallor, ulceration, and haemorrhage and is associated with a pronounced reduction in blood flow at the site of damage.8 9 Kitahora and Guth 0 1 2 3 4 observed that aspirin in hydrochloric acid topically applied in rats induced thrombi in the stomach (antrum and body the mucosal microvessels and a cessation of mucosal blood flow. 19 This may be of potential clinical significance, clearly contribute to models of ischaemia reduced by allopuri inhibitor.5-7 Indeed that allopurinol car methacin induced inj that indomethacin pr in gastric blood floi hours of administr effect ofNSAIDs on: either focally or globE oxidation of xanthir known. Our data hypothesis that local aspirin in humans m reactive oxygen m xanthine oxidase as reduced the increase luminescence. We w ever, that this was a mucosal protection.
Salicylate compoui nised as having a NSAID induced gas underlying mechani Sodium salicylate wa aspirin and indomi ulceration in rats22 bleeding in humans.2 emerged suggesting sessed similar prope: terally to rats it was f effect against various including alcohol an Aspirin + placebo as free oxygen radicals not indomethacin27 (although it did prevent gastric damage in animal small bowel ulceration induced by indomethareperfusion, and may be cin). 28 The mechanism for this antiulcer activinol, a xanthine oxidase ity was not fully explained, but it was thought one study does suggest to be independent of prostaglandin formation. n protect against indo-It was suggested in the earlier studies that the jury in rats.20 It is known protective effect of sodium salicylate was in oduces a global reduction part due to competition for the active w in humans within 24 cyclooxygenase catalytic site29 or a reduction *ation.21 22 Whether the in drug absorption.30 There was no evidence of human gastric blood flow, reduced drug absorption or a reversal of ally, is sufficient to induce cyclooxygenase inhibition in this study as sulie dehydrogenase is not phasalazine failed to change the aspirin inindirectly support the duced suppression of prostaglandin synthesis. 1 ischaemia produced by Since then, much evidence has accumulated Light induce the release of that sulphasalazine has antioxidant activity, in etabolites produced by addition to its various other anti-inflammatory allopurinol substantially properties. It reacts with free oxygen radicals in in aspirin induced chemi-the colon of patients with inflammatory bowel ere unable to show, how-disease3' and has been shown to inhibit issociated with significant myeloperoxidase and superoxide release in an animal model32 and stimulated human neutronds have long been recog-phils33-37 respectively. This is the first study to protective effect against show that sulphasalazine acts as an antioxidant stric injury, although the in the human stomach, a mechanism that may ism has been obscure. partly explain the previous identified gastric s shown to protect against protective effects of salicylates. Aspirin may ethacin induced gastric induce injury by several mechanisms, however, 3 24 and gastrointestinal and the reduction of free oxygen radicals was 5 Lanza score Figure 5 : Frequency distribution graphs for Lanza 45 46 which might permit the unopposed synthesis and release of free oxygen radicals by neutrophils activated after NSAID induced gastric mucosal injury.4
Changes in absorption may explain the otherwise paradoxical protection of the duodenum by vitamin C. The pKa of ascorbic acid is 41.39 Hence at normal gastric pH, vitamin C is present predominantly as ascorbic acid, which will tend to be oxidised to dehydroascorbic acid as the pH rises in the duodenum. There is some evidence that vitamin C is more readily absorbed as dehydroascorbic acid.52 53 This may partly be because it is less ionised at physiological pH and is promptly reduced to ascorbic acid and thereby trapped within the epithelium.52 53 It is possible that this mechanism allows sufficient absorption of vitamin C to enable it to act as an antioxidant within the duodenal mucosa.
Vitamin C has other actions that may be relevant to mucosal repair and therefore must be considered. The role in wound healing through the synthesis of collagen, the formation of intercellular matrix, and angiogenesis is well established.54 Furthermore, ascorbate is an important reductant in the a-amidation of peptide hormones, including gastrin. Wound healing improves once vitamin C deficiency is corrected55 and ascorbic acid has been used with some success in the treatment of leg ulcers56 and pressure sores.48 This may represent another mechanism by which vitamin C encourages mucosal healing in the duodenum.
Aspirin induces gastroduodenal injury by a variety of mechanisms. We have shown that aspirin increases the production of gastric mucosal reactive oxygen metabolites, which are likely to act as a further source of injury. Our data suggest that oxygen radical release may occur after neutrophil activation and an ischaemia-reperfusion injury, both of which mechanisms have been implicated in NSAID induced gastric mucosal damage. Antioxidants did reduce antral oxygen radical release, but failed to provide gastric mucosal protection, reflecting the multifactorial nature of aspirin induced injury. Vitamin C seemed to have a protective effect on aspirin induced duodenal injury, the mechanism for which requires further elucidation. Preferential absorption in the duodenum may enable it to accumulate and act as an antioxidant within the mucosa, but it has other actions in tissue repair, which may be equally important.
